scholarly article | Q13442814 |
P356 | DOI | 10.1016/J.BIOMATERIALS.2011.03.035 |
P698 | PubMed publication ID | 21459440 |
P50 | author | Olivia M. Merkel | Q38544075 |
P2093 | author name string | Thomas Kissel | |
Janos Szebeni | |||
László Rosivall | |||
Rudolf Urbanics | |||
Peter Bedocs | |||
Zoltán Rozsnyay | |||
Miklós Toth | |||
P433 | issue | 21 | |
P921 | main subject | biophysics | Q7100 |
anaphylaxis | Q168800 | ||
bioengineering | Q580689 | ||
P1104 | number of pages | 7 | |
P304 | page(s) | 4936-4942 | |
P577 | publication date | 2011-04-02 | |
P1433 | published in | Biomaterials | Q15751139 |
P1476 | title | In vitro and in vivo complement activation and related anaphylactic effects associated with polyethylenimine and polyethylenimine-graft-poly(ethylene glycol) block copolymers | |
P478 | volume | 32 |
Q64983889 | Advances in nanotechnology and asthma. |
Q42240132 | Block copolymers containing a hydrophobic domain of membrane-lytic peptides form micellar structures and are effective gene delivery agents |
Q37557225 | Crosslinked linear polyethylenimine enhances delivery of DNA to the cytoplasm |
Q28659480 | Current progress in gene delivery technology based on chemical methods and nano-carriers |
Q91992110 | Delivery of Anti-miRNA for Triple-Negative Breast Cancer Therapy Using RNA Nanoparticles Targeting Stem Cell Marker CD133 |
Q47148640 | Diblock Copolymer Hydrophobicity Facilitates Efficient Gene Silencing and Cytocompatible Nanoparticle-Mediated siRNA Delivery to Musculoskeletal Cell Types. |
Q60998516 | Engineering Intravenously Administered Nanoparticles to Reduce Infusion Reaction and Stop Bleeding in a Large Animal Model of Trauma |
Q35675219 | Enhancement of airway gene transfer by DNA nanoparticles using a pH-responsive block copolymer of polyethylene glycol and poly-L-lysine |
Q35878088 | Functional properties and biodistribution of poly(triethylenetetramine/cystamine bisacrylamide) and poly(triethylenetetramine/cystamine bisacrylamide)- poly(ethylene glycol) mixtures formed with nucleic acid |
Q28394137 | Highly PEGylated DNA Nanoparticles Provide Uniform and Widespread Gene Transfer in the Brain |
Q38564991 | Hypersensitivity to intravenous iron: classification, terminology, mechanisms and management |
Q50975037 | Improved siRNA delivery efficiency via solvent-induced condensation of micellar nanoparticles |
Q52688127 | In vitro and in vivo delivery of siRNA via VIPER polymer system to lung cells. |
Q90212206 | Infusion Reactions Associated with the Medical Application of Monoclonal Antibodies: The Role of Complement Activation and Possibility of Inhibition by Factor H |
Q37633436 | Lung gene therapy with highly compacted DNA nanoparticles that overcome the mucus barrier |
Q91741380 | Nanotechnology bring a new hope for asthmatics |
Q40039105 | New perspectives in nanotherapeutics for chronic respiratory diseases. |
Q41280301 | New polymer of lactic-co-glycolic acid-modified polyethylenimine for nucleic acid delivery |
Q39169193 | Polyplex Evolution: Understanding Biology, Optimizing Performance |
Q40736574 | Post-Transcriptional Regulation of the GASC1 Oncogene with Active Tumor-Targeted siRNA-Nanoparticles |
Q42592314 | Regulating Biocompatibility of Carbon Spheres via Defined Nanoscale Chemistry and a Careful Selection of Surface Functionalities |
Q47097375 | Size, Shape, and Sequence-Dependent Immunogenicity of RNA Nanoparticles |
Q42921833 | Solid-phase supported design of carriers for therapeutic nucleic acid delivery |
Q35742894 | Structure and biological activity of pathogen-like synthetic nanomedicines |
Q30277809 | Targeted gene transfer to the brain via the delivery of brain-penetrating DNA nanoparticles with focused ultrasound |
Q38112504 | Understanding the correlation between in vitro and in vivo immunotoxicity tests for nanomedicines |
Search more.